Please ensure Javascript is enabled for purposes of website accessibility

CVS Caremark and the Snickers Factor

By Timothy M. Otte – Updated Apr 5, 2017 at 9:29PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CVS steams higher despite general retail woes.

The soft economy has hit some retail sectors hard. But there are still pockets of life, and CVS Caremark (NYSE: CVS) is one of the companies leading the way. One reason is what you could call the "Snickers Factor."

Chief Financial Officer David Rickard noted on the conference call that consumers may be hesitating to buy large-ticket discretionary items, but small-ticket items like Snickers bars still are finding their way into shopping baskets. Of course, front-end (retail) items only make up about 15% of revenue for CVS, but they are an important driver of transaction size and overall profitability. 

Total revenue for the first quarter grew 62%, to $21.3 billion. Keep in mind, however, that the Caremark segment was part of CVS for only a small portion of last year's first quarter. Retail comp sales continued to steam ahead at 3.9% -- noticeably slower than the torrid 7.5% comps in last year's first quarter, but still strong. Front-end comps were slightly stronger than the prescription business.

Pharmacy benefit management (PBM) revenue grew 2.3% on a full-quarter basis -- as if Caremark had been part of CVS for the full quarter last year. About one-third of these contracts come up for renewal each year, and CVS is pleased with the renewal rates it is seeing so far, including some important core accounts like AT&T (NYSE: T) and 3M (NYSE: MMM).

Earnings per share of $0.51 were 18.6% above last year, as acquisition-related expense synergies more than offset higher interest expense and a larger share base resulting from the acquisition of Caremark.

Management is also touting its success with in-store MinuteClinics, serving 300,000 customers this past quarter. At 510 clinics in operation, that works out to 6.5 customers a day, which doesn't sound like droves to me. But CVS has a significant "first mover" advantage over Wal-Mart (NYSE: WMT) and Walgreen (NYSE: WAG) in this new venture. Management has decided to slow the growth of new clinics for the balance of 2008, to focus on expanding services and contracting with more third parties.

Overall, I continue to see CVS as one of the best-positioned retail growth companies. Selling at 21 times its trailing earnings, the stock is priced at a premium compared to the rest of the field. So Foolish investors looking for a bargain in retail stocks have no shortage of (seemingly) more attractive choices. But CVS looks like a solid choice to me at this point.

Related Foolishness:

3M and Wal-Mart are Motley Fool Inside Value selections. Try the investing service free for 30 days.

Fool contributor Timothy M. Otte surveys the retail scene from Dallas. He welcomes comments on his articles, and owns shares of Wal-Mart, but none of the other companies mentioned in this article. The Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$97.74 (-0.62%) $0.61
Walmart Stock Quote
Walmart
WMT
$131.31 (0.96%) $1.25
AT&T Inc. Stock Quote
AT&T Inc.
T
$15.67 (-2.12%) $0.34
Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$32.69 (-0.43%) $0.14
3M Company Stock Quote
3M Company
MMM
$113.00 (0.01%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.